Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesAtenolol Hepatotoxicity: Report of a Complicated Case
Annals of Pharmacotherapy, 09/25/09
Dumortier J et al. – Despite the fact that Beta–blocker–induced hepatotoxicity is probably extremely rare, it must be suspected and the drug therefore discontinued.
Related Articles
Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications
Hypertension, 11/17/09
Relevance Score: 84%
Mid-term results, and therapeutic management, for patients suffering hypertension after surgical repair of aortic coarctation
Cardiology in the Young, 10/19/09
Relevance Score: 83%
71-Year-Old Man With Chronic Kidney Failure and Sudden Change of Mental Status
Mayo Clinic Proceedings, 11/06/09
Relevance Score: 80%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09
Sponsor
Article Search
Sponsor